Please assess the completion status of the following clinical trial:

Trial Title: Long Term Vitamin D Therapy in HCV Treated Patients

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: PHASE3
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Chronic HCV infection (positive HCV Ab more than 6 months)~* Treated with pegylated interferon and ribavirin~Exclusion Criteria:~* Coinfection with Hepatitis B or Hepatitis D or Human Immunodeficiency Virus~* Previous non response to antiviral therapy.~* Other causes of chronic liver diseases as schistosomiasis, Wilson disease and alcoholic liver disease.

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 55 Years
- Healthy Volunteers: f

Study Arms:
- HCV patients under treatment (Type: EXPERIMENTAL): Fifty patients study group administered vitamin D were compared with 50 patients control group without vitamin D.~Dose of vitamin D 15,000 IU/week
- HCV without Vit D (Type: NO_INTERVENTION): None

Based on this trial design, predict the completion outcome and termination type (if applicable).